Evogene
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $347 | $334 | $314 | $312 |
Gross Profit | -8 | 204 | -1,970 | 155 |
EBITDA | -2,292 | -1,820 | -6,459 | -1,994 |
EBIT | -2,441 | -2,022 | -6,722 | -2,275 |
Net Income | -1,768 | -5,870 | -5,309 | 3,874 |
Net Change In Cash | 347 | 334 | 314 | 312 |
Free Cash Flow | -2,109 | -2,956 | -2,692 | -3,806 |
Cash | 9,351 | 8,511 | 12,956 | 5,626 |
Basic Shares | 12,199 | 9,738 | 8,718 | 8,716 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,853 | $5,577 | $2,982 | $1,675 |
Gross Profit | -241 | 3,197 | 1,492 | 766 |
EBITDA | -12,197 | -13,364 | -20,532 | -27,009 |
EBIT | -13,341 | -14,745 | -21,832 | -29,589 |
Net Income | -8,485 | -16,485 | -23,879 | -26,638 |
Net Change In Cash | 3,853 | 5,577 | 2,982 | 1,675 |
Free Cash Flow | -13,637 | -20,326 | -22,362 | -24,849 |
Cash | 12,956 | 15,301 | 20,772 | 28,980 |
Basic Shares | 7,874 | 5,697 | 4,568 | 4,121 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.13 |
2026-03-31 | -$0.61 |
2025-12-31 | -$0.61 |
2025-09-30 | -$0.46 |